Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 75.11M P/E - EPS this Y -1.40% Ern Qtrly Grth -
Income -14.64M Forward P/E -4.03 EPS next Y 13.70% 50D Avg Chg 7.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -12.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -57.00%
Recommedations 2.50 Quick Ratio 13.56 Shares Outstanding 26.33M 52W Low Chg 159.00%
Insider Own 28.17% ROA -90.42% Shares Float 19.31M Beta -1.12
Inst Own 9.31% ROE -159.89% Shares Shorted/Prior 118.58K/159.35K Price 2.90
Gross Margin - Profit Margin - Avg. Volume 508,666 Target Price 5.00
Oper. Margin - Earnings Date Aug 8 Volume 42,809 Change -4.92%
About Heartbeam, Inc.

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

Heartbeam, Inc. News
05/13/24 HeartBeam, Inc. (NASDAQ:BEAT) Q1 2024 Earnings Call Transcript
05/13/24 HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
05/09/24 HeartBeam Reports First Quarter 2024 Results
04/25/24 HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
04/09/24 HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
03/21/24 HeartBeam, Inc. (NASDAQ:BEAT) Q4 2023 Earnings Call Transcript
03/21/24 Q4 2023 Heartbeam Inc Earnings Call
03/20/24 HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
03/14/24 First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG
03/07/24 HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology
03/05/24 HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time
12/28/23 Insiders Of HeartBeam Are Up 49% On Their US$2.89m Purchase
12/14/23 HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights
11/15/23 HeartBeam, Inc. (NASDAQ:BEAT) Q3 2023 Earnings Call Transcript
11/14/23 HeartBeam Reports Third Quarter 2023 Financial Results
11/09/23 HeartBeam Announces Expansion of Its Scientific Advisory Board
11/07/23 HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias
10/31/23 HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time
09/27/23 Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer
09/26/23 HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team
BEAT Chatroom

User Image turuguru Posted - 1 day ago

$BEAT is attending HRS in Boston

User Image millboy800 Posted - 2 days ago

$BEAT 3636 watchers waiting for FDA approval…… tomorrow ( like free beer - tomorrow) it’s right around the corner.

User Image gapureau Posted - 5 days ago

$BEAT CEO stated last week they expect 1st FDA approval by end of 2nd Qtr. Should be very big boost to Stock when it happens. In meantime, everything seems to be improving for what company can do without FDA involved. https://ir.heartbeam.com/news-events/press-releases/detail/71/heartbeam-aimigo-recognized-for-digital-health Also like/own $cero, $nivf, $acon

User Image NetworkNewsWire Posted - 5 days ago

$BEAT - HeartBeam Inc. AIMIGo(TM) Recognized as ‘Best New ECG Technology Solution’ in Awards Program https://ibn.fm/91aZd

User Image BagmanBurns Posted - 5 days ago

$BEAT I’ll take $8. If so warrants should be trading around $1.50 -$2. Holding Warrants and waiting.

User Image NetworkNewsWire Posted - 1 week ago

$BEAT - HeartBeam Inc. Releases Q1 2024 Financial, Operational Report https://ibn.fm/q8syr

User Image BagmanBurns Posted - 1 week ago

$BEAT “Anticipation of FDA clearance for the AIMIGo system by the end of Q2 2024 and launch by 2024 end.” This is a warrant play for me. BEAT gets FDA approval. We won’t see warrants trade under $1 again.

User Image Peterman25 Posted - 1 week ago

@millboy800 We should have answers by the end of June. $BEAT

User Image millboy800 Posted - 1 week ago

$BEAT I can’t believe I’m saying this but “I think we’re closer”. It has to happen this quarter.

User Image epsguid Posted - 1 week ago

$BEAT reported a loss of $0.17 via @eWhispers http://eps.sh/d/beat

User Image Stock_Titan Posted - 1 week ago

$BEAT HeartBeam Reports First Quarter 2024 Results https://www.stocktitan.net/news/BEAT/heart-beam-reports-first-quarter-2024-7vdqyc7zaazu.html

User Image Garfeild Posted - 1 week ago

$BEAT earnings day and this doesn’t look promising. Sold. will revisit later

User Image millboy800 Posted - 1 week ago

$BEAT sooooo….. what to expect today? I’m thinking revenue is not up or down. Sales? Not yet. maybe orders waiting to be filled? Nope. How about FDA approval? We’re close? Ugh! Let’s just trade between $1.95 and $2.20 for another month. FDA

User Image BagmanBurns Posted - 1 week ago

$BEAT “HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time” Ok boys, it’s game time !

User Image Stocksrockman Posted - 1 week ago

$RETO huge run here $WAVD watch $BEAT moving up everyday $IMTE short squeeze is coming Lots of hype Trending everywhere

User Image Deadman3906 Posted - 2 weeks ago

$JUST $BEAT $IT

User Image Oil_Pal Posted - 2 weeks ago

$BEAT I will add once it hits 1.7 Afterwards it will climb again 😏

User Image gapureau Posted - 2 weeks ago

$BEAT So I like today's action on the 1 month chart, but what does it really mean without any volume? At least the day traders did not dump at the close. Hopefully we see some News soon!

User Image Will2ride1 Posted - 2 weeks ago

$BEAT drop so I can add more

User Image gapureau Posted - 04/30/24

$BEAT Never seen AH bid drop so low so fast. Any news pending that I missed????

User Image turuguru Posted - 04/26/24

$BEAT their new job opening: https://www.linkedin.com/jobs/view/3911735732/?alternateChannel=search&refId=A88zV2loK883YV5sljuZFQ%3D%3D&trackingId=s6ZoLvAIVMjyJmz4dviVAA%3D%3D. This application gives a little more insight what they are actually producing and how far they are. I don't think they would be going further with this app if they knew that their 3D vector ECG recording device was a failure.

User Image Fookmearse Posted - 04/25/24

$BEAT stop on by to $BTCY

User Image gapureau Posted - 04/25/24

$BEAT While I have high hopes for the future, seems it will be some time before anything happens. Will be game changer when FDA approval happens but from what I have read they are not as close as we thought. If management wants to clarify, please do. Else , I have already trimmed my holdings but plan to buy back once I feel better about the time line....

User Image Stock_Titan Posted - 04/25/24

$BEAT HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time https://www.stocktitan.net/news/BEAT/heart-beam-to-host-first-quarter-2023-results-conference-call-on-qr5g32rmxnlv.html

User Image Peterman25 Posted - 04/24/24

$BEAT On the last earnings call they mentioned that they were getting ready to finalize answers to FDA questions and submit them. Their regulatory affairs person used to be part of the team at the FDA that dealt with these approvals. So, smart hire. Should have excellent knowledge on how to navigate this process. They also mentioned hoping for approval by end of Q2 as that aligned with the end of their study. That’s what I can remember. Hope it helps. Chest pain is the number one reason people go to the ER. According to their last presentation, TAM in the USA is $14B.

User Image TradingtooRetire Posted - 04/24/24

$BEAT Wondering if anyone can confirm/shed some light on a few things: 1). Beat hired a regulatory affairs person recently who is now handling the FDA approval, correct? if so, would imagine the timeline they provided for q2 approval should hold a little more weight now? 2). What is the total market opportunity in terms of dollars for this device? thanks in advance

User Image TickerDD_com Posted - 04/23/24

From 4/9/2024, looking back across 22 Month-Ends for BEAT, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had All Positives (100%) $BEAT #BEAT #BEATStock #TickerDD https://www.youtube.com/watch?v=WRc2w5T5bRY

User Image BagmanBurns Posted - 04/23/24

$BEAT still waiting for that FDA news.

User Image Shawn0331 Posted - 1 month ago

$BEAT Come on FDA

User Image VrtcIl Posted - 1 month ago

$BEAT still gaining momentum towards 2$. The uptrend is supported by consistent increased highs and increased lows, with notable volume signaling increased buying interest. Price: 1.97 Float: 19.5M Short Float: 0.2 % 💰 Dollar Volume: 2.1K ℹ️ USA | Health Information Services

Analyst Ratings
Benchmark Speculative Buy May 13, 24
Benchmark Speculative Buy Mar 25, 24
Benchmark Speculative Buy Nov 16, 23
Benchmark Speculative Buy Aug 24, 23
Alliance Global Partners Buy May 19, 23
Benchmark Speculative Buy May 19, 23
Benchmark Speculative Buy Mar 21, 23
Alliance Global Partners Buy Dec 2, 22
Benchmark Speculative Buy Dec 20, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
de Urioste George Director Director Sep 29 Sell 2.06 5,500 11,330 36,129 10/03/23
de Urioste George Director Director Sep 27 Sell 2.08 9,834 20,455 41,629 09/29/23
de Urioste George Director Director Sep 22 Sell 2.15 7,393 15,895 51,463 09/27/23
de Urioste George Director Director Sep 20 Sell 2.44 983 2,399 58,856 09/22/23
de Urioste George Director Director Sep 15 Sell 2.45 9,269 22,709 59,839 09/19/23
de Urioste George Director Director Sep 13 Sell 2.01 10,000 20,100 69,108 09/15/23
Brounstein Richard Chief Financial Offi.. Chief Financial Officer Nov 02 Option 0.0003 759 111,164 11/02/22
Brounstein Richard Chief Financial Offi.. Chief Financial Officer Sep 02 Option 0.0003 757 109,645 09/02/22
Brounstein Richard Chief Financial Offi.. Chief Financial Officer Aug 02 Option 0.0003 757 108,888 08/02/22
Brounstein Richard Chief Financial Offi.. Chief Financial Officer Jul 05 Option 0.0003 757 108,131 07/06/22
Brounstein Richard Chief Financial Offi.. Chief Financial Officer May 02 Option 0.0003 757 106,617 05/02/22
BROUNSTEIN RICHARD D CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Nov 11 Option 4.2 29,197 122,627 92,075 11/15/21
BROUNSTEIN RICHARD D CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Nov 11 Buy 5.99 5,000 29,950 97,075 11/15/21
Ortigas-Wedekind Marga Director Director Nov 11 Option 4.2 7,824 32,861 7,824 11/15/21
Ortigas-Wedekind Marga Director Director Nov 11 Buy 5.99 9,000 53,910 16,824 11/15/21
Elfrink Willhem Director Director Nov 11 Option 4.2 332,407 1,396,109 437,861 11/15/21